Donald Notman
Fortune : 2 M $ au 30/06/2026
Fortune : 2 M $ au 30/06/2026
Donald Notman is Chief Operating Officer at Ocular Therapeutix, Inc. since 2026.
Formerly, Mr. Notman was Managing Director & Head-Private Capital Markets at Leerink Partners LLC.
From 2014 to 2017, Mr. Notman was Chief Financial Officer & Senior Vice President at Thrasos Therapeutics, Inc. Education includes an undergraduate degree from Middlebury College and an MBA from Tuck School of Business at Dartmouth.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCULAR THERAPEUTIX INC 0,09 % | 31/03/2026 | 184 662 ( 0,09 % ) | 2 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Directeur des opérations | 29/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Directeur Financier/CFO | 01/03/2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national